Actinium Pharmaceuticals, Inc. (ATNM)
1.56
+0.18
(+13.04%)
USD |
NYAM |
Oct 22, 15:50
Actinium Pharmaceuticals Market Cap : 49.05M for Oct. 22, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 43.39M |
| October 20, 2026 | 44.02M |
| October 19, 2026 | 41.50M |
| October 16, 2026 | 35.53M |
| October 15, 2026 | 33.33M |
| October 14, 2026 | 30.64M |
| October 13, 2026 | 31.43M |
| October 12, 2026 | 33.33M |
| October 09, 2026 | 34.59M |
| October 08, 2026 | 33.96M |
| October 07, 2026 | 33.64M |
| October 06, 2026 | 34.90M |
| October 05, 2026 | 37.73M |
| October 02, 2026 | 36.79M |
| October 01, 2026 | 36.16M |
| September 30, 2026 | 35.21M |
| September 29, 2026 | 35.84M |
| September 28, 2026 | 37.10M |
| September 25, 2026 | 37.73M |
| September 24, 2026 | 37.42M |
| September 23, 2026 | 37.10M |
| September 22, 2026 | 36.79M |
| September 21, 2026 | 37.73M |
| September 18, 2026 | 38.36M |
| September 17, 2026 | 37.42M |
| Date | Value |
|---|---|
| September 16, 2026 | 38.99M |
| September 15, 2026 | 39.30M |
| September 14, 2026 | 40.24M |
| September 11, 2026 | 44.02M |
| September 10, 2026 | 41.19M |
| September 09, 2026 | 38.67M |
| September 08, 2026 | 38.67M |
| September 04, 2026 | 32.38M |
| September 03, 2026 | 33.01M |
| September 02, 2026 | 31.44M |
| September 01, 2026 | 31.30M |
| August 31, 2026 | 32.07M |
| August 28, 2026 | 31.76M |
| August 27, 2026 | 31.44M |
| August 26, 2026 | 31.76M |
| August 25, 2026 | 33.96M |
| August 24, 2026 | 33.01M |
| August 21, 2026 | 34.59M |
| August 20, 2026 | 35.21M |
| August 19, 2026 | 35.53M |
| August 18, 2026 | 33.96M |
| August 17, 2026 | 33.01M |
| August 14, 2026 | 32.70M |
| August 13, 2026 | 30.31M |
| August 12, 2026 | 25.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.494B |
| Alnylam Pharmaceuticals, Inc. | 30.26B |
| Anika Therapeutics, Inc. | 280.11M |
| Savara, Inc. | 924.30M |
| Vericel Corp. | 2.191B |
Market Cap Related Metrics
| PE Ratio | 4.373 |
| PS Ratio | 1.390 |
| Price to Book Value | 1.619 |
| Price | 1.56 |
| Earnings Yield | 22.87% |
| Operating PE Ratio | 5.103 |
| Normalized PE Ratio | 4.373 |